News Related to: Patient Care
-
This Little Girl’s Seizures Won’t Stop. Her Parents Need Your Advice.
Inexplicable Seizures. As soon as mother and child arrived in the E.R., Sadie was given Ativan, a fast-acting sedative that is the drug of choice in treating ongoing seizures.
-
What you need to know about the 'polio-like' illness popping up around the U.S.
Dr. Kiran Thakur spoke with the New York Daily News ...
-
Biomarkers in Spinal Fluid Offer Method for Alzheimer's Diagnosis
Our study shows that this is a good test that can be used in clinical practice to reliably exclude other diagnoses in patients suspected of having Alzheimer's disease," ...
-
23andMe Said He Would Lose His Mind. Ancestry Said the Opposite. Which Was Right?
Mr. Fender then tracked down Jill Goldman, a genetic counselor specializing in dementia at the Taub Institute at Columbia University Irving Medical Center, who described a multistep process of...
-
So THAT’S The Difference Between Alzheimer’s And Dementia
Within this group is Alzheimer’s disease, which accounts for more than 50 percent of dementia diagnoses, according to Elise Caccappolo, associate professor of neuropsychology and director of the...
-
Brain's Dumped DNA May Lead to Stress, Depression
New research suggests genetic material from the mitochondria can trigger an immune response throughout the body.
-
Memory Peaks in Late Summer in Older Adults
Memory and concentration peak in the late summer for adults in their 70s, 80s, and 90s according to a new study co-led by Columbia neurologist Philip De Jager, MD, PhD. The findings suggest that...
-
Inside NYP: Dr. Cigdem Akman
The chief of child neurology reflects on how she left Turkey to advance her medical career and, in the process, found a new home in the U.S.
-
ColumbiaDoctors Neurologists Named to NYMag “Best Doctors 2018”
Congratulations to Drs. Cigdem Akman (Child Neurology), Carl Bazil, ...
-
New Drug Shows Promise For Patients With Progressive Multiple Sclerosis
A new drug for Multiple Sclerosis is showing promise. A study shows the experimental drug, called Ibudilast, slowed brain atrophy or shrinkage by almost 50%. The study, funded by the National...
